![]() |
Volumn 85, Issue 7, 1996, Pages 685-689
|
Comparison of the pharmacokinetics of dolasetron and its major active metabolite, reduced dolasetron, in dog
|
Author keywords
[No Author keywords available]
|
Indexed keywords
(2ALPHA,6ALPHA,8ALPHA,9ABETA)OCTAHYDRO 3 HYDROXY 2,6 METHANO 2H QUINOLIZIN 8 YL 1H INDOLE 3 CARBOXYLIC ACID;
DOLASETRON MESILATE;
DRUG METABOLITE;
SEROTONIN ANTAGONIST;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL MODEL;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DOG;
DOSE TIME EFFECT RELATION;
DRUG ABSORPTION;
DRUG BIOAVAILABILITY;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG ELIMINATION;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
RECEPTOR BLOCKING;
STRUCTURE ACTIVITY RELATION;
VOMITING;
|
EID: 0030017746
PISSN: 00223549
EISSN: None
Source Type: Journal
DOI: 10.1021/js960041m Document Type: Article |
Times cited : (10)
|
References (15)
|